# 3i Plc

> 3i Plc is a VC fund backing Biopharma, Biotechnology and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Apr 2004
- Lead investor: 50%
- Last updated: Aug 2026

3i Plc is a VC fund focused on Biopharma and Biotechnology. Global Private Equity

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 2 | 100% |
| Biotechnology | 2 | 100% |
| Health Care | 1 | 50% |
| Neuroscience | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Evotec Neurosciences | Evotec Neurosciences GmbH engages in the discovery and development of small molecule drugs. | $27.4M | Series A | Apr 02, 2004 |  |
| Oxagen | Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom. | $39.3M |  | Dec 21, 2000 |  |

2 of 2 investments shown.

## Co-investors
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 1 deal together
- [BankInvest Biomedical Venture](https://shizune.co/investors/profile/bankinvest-biomedical-venture) — VC Fund, 1 deal together
- Credit Suisse First Boston — VC Fund, 1 deal together
- [Invesco](https://shizune.co/investors/profile/invesco-perpetual) — VC Fund, 1 deal together
- [MVM Life Science Partners](https://shizune.co/investors/profile/mvm-life-science-partners) — VC Fund, 1 deal together
- OppenheimerFunds — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does 3i Plc invest in?

3i Plc invests primarily in Biopharma, Biotechnology and Health Care startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did 3i Plc last invest?

The most recent investment recorded for 3i Plc closed in Apr 2004. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co